Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 31, 2023 - Issue 6: COVID-19 and the Eye
Submit an article Journal homepage
152
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Multiple Evanescent White Dot Syndrome Following Adenovirus Vector-Based COVID-19 Vaccine (Covishield)

Abhilasha Baharania Uvea Services, Neoretina Eyecare Institute, Nampally, IndiaCorrespondence[email protected]
View further author information
, DNB, FRCS, FICO &
Raja Rami Reddyb Retina Services, Neoretina Eyecare Institute, Nampally, IndiaView further author information
, MD, FRCS
Pages 1299-1304 | Received 20 Dec 2022, Accepted 13 Mar 2023, Published online: 12 Apr 2023

References

  • [Internet]. https://covid19.who.int/.
  • Shu Y, McCauley J. GISAID: global initiative on sharing all influenza data–from vision to reality. Eurosurveillance. March 30, 2017;22(13):30494. doi:10.2807/1560-7917.ES.2017.22.13.30494.
  • Mascellino MT, Di Timoteo F, De Angelis M, Oliva A. Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety. Infect Drug Resist. 2021;14:3459. doi:10.2147/IDR.S315727.
  • Jampol LM, Sieving PA, Pugh D, Fishman GA, Gilbert H. Multiple evanescent white dot syndrome: i. Clinical findings. Arch Ophthalmol. May 1, 1984;102(5):671–674. doi:10.1001/archopht.1984.01040030527008.
  • Baharani A, Errera MH, Jhingan M, et al. Choroidal imaging in uveitis: an update. Surv Ophthalmol. January 7, 2022;67:965–990. doi:10.1016/j.survophthal.2022.01.001.
  • Ng CC, Jumper JM, Cunningham JE. Multiple evanescent white dot syndrome following influenza immunization-A multimodal imaging study. Am J Ophthalmol Case Rep. September 1, 2020;19:100845. doi:10.1016/j.ajoc.2020.100845.
  • Rabinovitch T, Ben-Arie-Weintrob Y, Hareuveni-Blum T, et al. Uveitis after the BNT162b2 mRNA vaccination against SARS-CoV-2 infection: a possible association. Retina. December 1, 2021;41(12):2462–2471. doi:10.1097/IAE.0000000000003277.
  • Yasuda E, Matsumiya W, Maeda Y, et al. Multiple evanescent white dot syndrome following BNT162b2 mRNA COVID-19 vaccination. Am J Ophthalmol Case Rep. June 1, 2022;26:101532. doi:10.1016/j.ajoc.2022.101532.
  • Alhabshan R, Scales D. Multiple evanescent white dot syndrome developing three days following administration of mRNA-1273 booster vaccine: case report. Case Rep Ophthalmol. 2022;13:570–577. doi:10.1159/000525687.
  • Inagawa S, Onda M, Miyase T, et al. Multiple evanescent white dot syndrome following vaccination for COVID-19: a case report. Medicine. January 1, 2022;101(2):e28582. doi:10.1097/MD.0000000000028582.
  • Gargouri MA, Yousfi N, Toutain J, et al. Multiple evanescent white dot syndrome following COVID-19 mRNA vaccination. Ocul Immunol Inflammation. October 2022;1:1–5. doi:10.1080/09273948.2022.2127782.
  • Lin KS, Hsieh MH. Multiple evanescent white dot syndrome following medigen vaccine biologics corporation COVID-19 vaccination. Ocul Immunol Inflamm. April 2022;17:1–4. doi:10.1080/09273948.2022.2127782.
  • Smith E, Tran T, Gillies A, Yeung S, Ma PE. Multiple evanescent white dot syndrome following COVID-19 mRNA vaccination in two patients. Ocul Immunol Inflamm. January 2022;30:1–4. doi:10.1080/09273948.2022.2032198.
  • Tomishige KS, Novais EA, Finamor LP, Nascimento HM, Belfort R Jr. Multiple evanescent white dot syndrome (MEWDS) following inactivated COVID-19 vaccination (Sinovac-CoronaVac). Arq Bras Oftalmol. January 21, 2022;85:186–189. doi:10.5935/0004-2749.20220070.
  • Bouhout S, Hébert M, Vadboncoeur J, Aubin MJ. Multiple evanescent white dot syndrome following COVID-19 vaccines. Can J Ophthalmol. October 23, 2022. doi:10.1016/j.jcjo.2022.10.002.
  • Elsayed ME, Kozak I. Pharmacologically induced uveitis. Surv Ophthalmol. September 1, 2021;66(5):781–801. doi:10.1016/j.survophthal.2021.01.003.
  • Zhuang CL, Lin ZJ, Bi ZF, et al. Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response. Emerging Microbes Infect. January 1, 2021;10(1):365–375. doi:10.1080/22221751.2021.1891002.
  • [Internet]. https://dashboard.cowin.gov.in/.
  • Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. August, 1981;30(2):239–245. doi:10.1038/clpt.1981.154.
  • Singh RB, Parmar UP, Kahale F, Agarwal A, Tsui E. Vaccine-associated uveitis after COVID-19 vaccination: vaccine adverse event reporting system database analysis. Ophthalmology. February 1, 2023;130(2):179–186. doi:10.1016/j.ophtha.2022.08.027.
  • Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. September 1, 2022;22(9):1293–1302. doi:10.1016/S1473-3099(22)00320-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.